These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW. Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882 [Abstract] [Full Text] [Related]
8. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, Avent ND, Soothill PW. Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662 [Abstract] [Full Text] [Related]
13. beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. Sekizawa A, Farina A, Koide K, Iwasaki M, Honma S, Ichizuka K, Saito H, Okai T. Prenat Diagn; 2004 Sep; 24(9):697-700. PubMed ID: 15386451 [Abstract] [Full Text] [Related]
15. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia. Byrne BM, Crowley A, Taulo F, Anthony J, O'Leary JJ, O'Herlihy C. Hypertens Pregnancy; 2003 Sep; 22(2):157-64. PubMed ID: 12909000 [Abstract] [Full Text] [Related]